Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase
Inflammation Research2001Vol. 50(11), pp. 561–569
Citations Over TimeTop 10% of 2001 papers
Jon G. Mabley, Prakash G. Jagtap, Mauro Perretti, Stephen J. Getting, Andrew L. Salzman, László Virág, Éva Szabó, Francisco García Soriano, Lucas Liaudet, Galaleldin E. Abdelkarim, György Haskó, A. V. Marton, Garry J. Southan, Csaba Szabó
Related Papers
- → Mechanisms of PARP inhibitor sensitivity and resistance(2018)476 cited
- → PARP inhibitor combination therapy(2016)215 cited
- → Quantification of PARP Activity in Human Tissues: Ex Vivo Assays in Blood Cells and Immunohistochemistry in Human Biopsies(2017)5 cited
- → Selectivity profile of the poly(ADP-ribose) polymerase (PARP) inhibitor, A-966492(2017)3 cited
- → Olaparib is an inhibitor of poly (ADP-Ribose) polymerase (PARP) Enzymes: A Review(2018)